The discovery of a novel Notch4-Wnt-GDF15 axis in controlling allergic asthma in mice, and its subsequent validation in patients with severe asthma, undoubtedly offers new therapeutic prospects for restoring pulmonary immune tolerance and maintaining systemic balance (Hammad and Lambrecht, 2020). Here, NOTCH4 is linked to allergic asthma.